Laboratorios Farmaceuticos ROVI Net Asset Momentum
Laboratorios Farmaceuticos ROVI net asset momentum. Laboratorios Farmaceuticos ROVI (ROVI) recorded a net asset momentum of 7.0% as of December 2024, with net assets of €581.54 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore how much does Laboratorios Farmaceuticos ROVI reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Laboratorios Farmaceuticos ROVI (2003–2024)
Net asset momentum of Laboratorios Farmaceuticos ROVI from 2003 to 2024. This chart tracks Laboratorios Farmaceuticos ROVI's year-over-year net asset growth across 22 annual reporting periods from 2003 to 2024. The most recent momentum reading is +7.0%, with net assets of €581.54 Million EUR as of December 2024. See Laboratorios Farmaceuticos ROVI (ROVI) shareholders funds for net asset value and shareholders' equity analysis.
Laboratorios Farmaceuticos ROVI Net Asset Momentum by Year (2003–2024)
Laboratorios Farmaceuticos ROVI net asset momentum by year from 2003 to 2024. The table below shows the complete annual net asset history for Laboratorios Farmaceuticos ROVI from 2003 to 2024, covering 22 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see market value of Laboratorios Farmaceuticos ROVI.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | €581.54 Million | €832.02 Million | €250.48 Million | ▲ +7.0% |
| 2023 | €543.49 Million | €799.88 Million | €256.39 Million | ▲ +4.2% |
| 2022 | €521.38 Million | €878.70 Million | €357.32 Million | ▲ +10.7% |
| 2021 | €470.98 Million | €732.68 Million | €261.70 Million | ▲ +26.0% |
| 2020 | €373.70 Million | €574.44 Million | €200.74 Million | ▲ +15.9% |
| 2019 | €322.39 Million | €511.21 Million | €188.82 Million | ▲ +12.1% |
| 2018 | €287.47 Million | €402.70 Million | €115.23 Million | ▲ +50.0% |
| 2017 | €191.69 Million | €298.38 Million | €106.69 Million | ▲ +4.5% |
| 2016 | €183.41 Million | €287.85 Million | €104.44 Million | ▲ +11.3% |
| 2015 | €164.78 Million | €263.85 Million | €99.06 Million | ▲ +4.0% |
| 2014 | €158.47 Million | €261.32 Million | €102.85 Million | ▲ +9.7% |
| 2013 | €144.46 Million | €235.92 Million | €91.46 Million | ▲ +14.2% |
| 2012 | €126.45 Million | €222.36 Million | €95.92 Million | ▲ +10.9% |
| 2011 | €113.98 Million | €228.07 Million | €114.09 Million | ▲ +9.5% |
| 2010 | €104.13 Million | €212.89 Million | €108.75 Million | ▲ +45.7% |
| 2009 | €71.50 Million | €165.91 Million | €94.42 Million | ▲ +47.6% |
| 2008 | €48.44 Million | €120.55 Million | €72.11 Million | ▼ -6.7% |
| 2007 | €51.92 Million | €112.16 Million | €60.23 Million | ▲ +101.2% |
| 2006 | €25.81 Million | €76.04 Million | €50.23 Million | ▼ -100.0% |
| 2005 | €4.80 Trillion | €8.15 Trillion | €3.35 Trillion | ▲ +164642253.7% |
| 2004 | €2.92 Million | €7.88 Billion | €7.88 Billion | ▼ -83.6% |
| 2003 | €17.80 Million | €48.60 Million | €30.80 Million | — |